» Articles » PMID: 35804908

Dynamic Interactions Between Tumor Cells and Brain Microvascular Endothelial Cells in Glioblastoma

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2022 Jul 9
PMID 35804908
Authors
Affiliations
Soon will be listed here.
Abstract

GBM is the most aggressive brain tumor among adults. It is characterized by extensive vascularization, and its further growth and recurrence depend on the formation of new blood vessels. In GBM, tumor angiogenesis is a multi-step process involving the proliferation, migration and differentiation of BMECs under the stimulation of specific signals derived from the cancer cells through a wide variety of communication routes. In this review, we discuss the dynamic interaction between BMECs and tumor cells by providing evidence of how tumor cells hijack the BMECs for the formation of new vessels. Tumor cell-BMECs interplay involves multiple routes of communication, including soluble factors, such as chemokines and cytokines, direct cell-cell contact and extracellular vesicles that participate in and fuel this cooperation. We also describe how this interaction is able to modify the BMECs structure, metabolism and physiology in a way that favors tumor growth and invasiveness. Finally, we briefly reviewed the recent advances and the potential future implications of some high-throughput 3D models to better understanding the complexity of BMECs-tumor cell interaction.

Citing Articles

Combined Strategies for Nanodrugs Noninvasively Overcoming the Blood-Brain Barrier and Actively Targeting Glioma Lesions.

Liu Y, Wu H, Liang G Biomater Res. 2025; 29:0133.

PMID: 39911305 PMC: 11794768. DOI: 10.34133/bmr.0133.


Blood-tumor barrier in focus - investigation of glioblastoma-induced effects on the blood-brain barrier.

Mathew-Schmitt S, Peindl M, Neundorf P, Dandekar G, Metzger M, Nickl V J Neurooncol. 2024; 170(1):67-77.

PMID: 39196480 PMC: 11446994. DOI: 10.1007/s11060-024-04760-w.


Peritumoral brain zone in glioblastoma: biological, clinical and mechanical features.

Ballestin A, Armocida D, Ribecco V, Seano G Front Immunol. 2024; 15:1347877.

PMID: 38487525 PMC: 10937439. DOI: 10.3389/fimmu.2024.1347877.


The development of a custom RNA-sequencing panel for the identification of predictive and diagnostic biomarkers in glioma.

Shirai Y, Ueno T, Kojima S, Ikeuchi H, Kitada R, Koyama T J Neurooncol. 2024; 167(1):75-88.

PMID: 38363490 PMC: 10978676. DOI: 10.1007/s11060-024-04563-z.


Glial Cell Adhesion Molecule (GlialCAM) Determines Proliferative versus Invasive Cell States in Glioblastoma.

De A, Lattier J, Morales J, Kelly J, Zheng X, Chen Z J Neurosci. 2023; 43(47):8043-8057.

PMID: 37722850 PMC: 10669794. DOI: 10.1523/JNEUROSCI.1401-23.2023.


References
1.
Prager B, Bhargava S, Mahadev V, Hubert C, Rich J . Glioblastoma Stem Cells: Driving Resilience through Chaos. Trends Cancer. 2020; 6(3):223-235. PMC: 8779821. DOI: 10.1016/j.trecan.2020.01.009. View

2.
Chaicharoenaudomrung N, Kunhorm P, Promjantuek W, Rujanapun N, Heebkaew N, Soraksa N . Transcriptomic Profiling of 3D Glioblastoma Tumoroids for the Identification of Mechanisms Involved in Anticancer Drug Resistance. In Vivo. 2019; 34(1):199-211. PMC: 6984103. DOI: 10.21873/invivo.11762. View

3.
Zhang W, DeMattia J, Song H, Couldwell W . Communication between malignant glioma cells and vascular endothelial cells through gap junctions. J Neurosurg. 2003; 98(4):846-53. DOI: 10.3171/jns.2003.98.4.0846. View

4.
Souberan A, Tchoghandjian A . Practical Review on Preclinical Human Glioblastoma Models: Advances and Challenges for Clinical Translation. Cancers (Basel). 2020; 12(9). PMC: 7563542. DOI: 10.3390/cancers12092347. View

5.
Skog J, Wurdinger T, van Rijn S, Meijer D, Gainche L, Sena-Esteves M . Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol. 2008; 10(12):1470-6. PMC: 3423894. DOI: 10.1038/ncb1800. View